Nuwellis, Inc. (NUWE) Form 8-K Material Events
Nuwellis, Inc. (NUWE) is a publicly traded company on the Nasdaq, categorized under SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NUWE
CIK: 1506492
Exchange: Nasdaq
SIC 3845: Electromedical & Electrotherapeutic Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJordan Iverson
Audit LocationMinneapolis, Minnesota, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-09-18 | — | SCHEDULE 13G/A Filing | 0001493152-26-043377 | View SEC Doc Filr Page |
| EFFECT | 2026-08-26 | — | EFFECT Filing | 9999999995-26-002772 | View SEC Doc Filr Page |
| 424B3 | 2026-08-26 | — | 424B3 | 0001140361-26-034472 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-25 | 8-K | 0001140361-26-034367 | View SEC Doc Filr Page |
| S-3 | 2026-08-18 | — | S-3 | 0001140361-26-033577 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003605 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001140361-26-032838 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001140361-26-032810 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0001493152-26-036633 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0001213900-26-086233 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-05 | — | SCHEDULE 13G Filing | 0000929638-26-002893 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-31 | 8-K | 0001140361-26-030985 | View SEC Doc Filr Page |
| 424B5 | 2026-08-03 | — | 424B5 | 0001140361-26-030566 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-24 | 8-K | 0001140361-26-029609 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-07 | 2026-07-07 | FORM DEF 14A | 0001539497-26-001914 | View SEC Doc Filr Page |
| 3 | 2026-07-01 | 2026-06-30 | FORM 3 | 0001140361-26-027213 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-26 | 2026-07-24 | PRE 14A | 0001539497-26-001874 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-23 | 8-K | 0001140361-26-026114 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-16 | 8-K | 0001140361-26-025614 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-08 | 8-K | 0001140361-26-024740 | View SEC Doc Filr Page |
| 424B4 | 2026-06-08 | — | 424B4 | 0001140361-26-024372 | View SEC Doc Filr Page |
| S-1MEF | 2026-06-05 | — | S-1MEF | 0001140361-26-024103 | View SEC Doc Filr Page |
| EFFECT | 2026-06-04 | — | EFFECT Filing | 9999999995-26-001889 | View SEC Doc Filr Page |
| CORRESP | 2026-06-04 | — | CORRESP Filing | 0001140361-26-023968 | View SEC Doc Filr Page |
| S-1/A | 2026-06-04 | — | S-1/A | 0001140361-26-023964 | View SEC Doc Filr Page |